HK1254547A1 - 抗病毒劑和治療病毒感染的方法 - Google Patents

抗病毒劑和治療病毒感染的方法

Info

Publication number
HK1254547A1
HK1254547A1 HK18113840.5A HK18113840A HK1254547A1 HK 1254547 A1 HK1254547 A1 HK 1254547A1 HK 18113840 A HK18113840 A HK 18113840A HK 1254547 A1 HK1254547 A1 HK 1254547A1
Authority
HK
Hong Kong
Prior art keywords
treatment
viral infection
virus agent
virus
agent
Prior art date
Application number
HK18113840.5A
Other languages
English (en)
Inventor
Graham John Hamilton Melrose
Michele Keryn Dilizia
Original Assignee
瑞克製藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016900595A external-priority patent/AU2016900595A0/en
Application filed by 瑞克製藥有限公司 filed Critical 瑞克製藥有限公司
Publication of HK1254547A1 publication Critical patent/HK1254547A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
HK18113840.5A 2016-02-19 2018-10-30 抗病毒劑和治療病毒感染的方法 HK1254547A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2016900595A AU2016900595A0 (en) 2016-02-19 Method for treatment of cancer or viral infection
AU2016902715A AU2016902715A0 (en) 2016-07-11 Method for treatment of cancer or viral infection
PCT/AU2017/050139 WO2017139849A1 (en) 2016-02-19 2017-02-17 Anti-virus agent and method for treatment of viral infection

Publications (1)

Publication Number Publication Date
HK1254547A1 true HK1254547A1 (zh) 2019-07-19

Family

ID=59624666

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113840.5A HK1254547A1 (zh) 2016-02-19 2018-10-30 抗病毒劑和治療病毒感染的方法

Country Status (8)

Country Link
US (2) US11045491B2 (zh)
EP (1) EP3416656B1 (zh)
JP (1) JP6812436B2 (zh)
CN (1) CN108472311B (zh)
AU (2) AU2017220391B2 (zh)
ES (1) ES2867453T3 (zh)
HK (1) HK1254547A1 (zh)
WO (1) WO2017139849A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023516272A (ja) * 2020-01-31 2023-04-19 レッセ ファーマシューティカルズ リミテッド 生物活性コポリマーの調製のためのプロセス

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2112381B (en) * 1981-09-30 1986-08-28 Nat Res Dev Cyclic ether and thioether derivatives for use as diluents in sustained release compositions
NZ222979A (en) * 1986-12-23 1990-09-26 Biopolymers Ltd Polymeric biocidal or biostatic compounds and compositions
CN87108390A (zh) * 1986-12-23 1988-09-21 生物聚合物有限公司 抑制生物和杀生物的组合物
AUPN327695A0 (en) 1995-05-30 1995-06-22 Chemeq Pty. Limited Chemotherapeutic compositions
US6060571A (en) 1996-02-22 2000-05-09 Degussa Aktiengesellschaft Acrolein-releasing copolymers
ATE201218T1 (de) 1996-02-22 2001-06-15 Degussa Acrolein freisetzende copolymere
US6060235A (en) * 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US6803356B1 (en) * 2000-02-16 2004-10-12 Chemeq Ltd. Antimicrobial polymeric compositions
US7629002B2 (en) 2000-02-16 2009-12-08 Chemeq Ltd. Antimicrobial polymeric compositions and method of treatment using them
NZ533811A (en) 2002-01-18 2005-07-29 Chemeq Ltd Method of treatment of gastrointestinal disease and polymeric composition for use therein
AUPS327102A0 (en) * 2002-06-28 2002-07-18 Chemeq Ltd Method of treatment or prophylaxis of gastrointestinal diseases
JP4680926B2 (ja) * 2003-11-06 2011-05-11 ケメック・リミテッド ポリアクロレインの製造方法
WO2009059350A1 (en) 2007-11-07 2009-05-14 Recce Pty Ltd Anti-microbial polymers and their compositions
EP2186521A1 (en) 2008-11-14 2010-05-19 Mergemeier Steffen Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound
AU2010100972A4 (en) * 2009-10-19 2010-10-07 Chemeq Ltd Topical antimicrobial compositions
WO2011047420A1 (en) * 2009-10-19 2011-04-28 Chemeq Ltd Cosmetic compositions
WO2015160940A1 (en) * 2014-04-15 2015-10-22 President And Fellows Of Harvard College Bi-specific agents
EP3220923B1 (en) * 2014-11-18 2019-08-28 Recce Pharmaceuticals Ltd Copolymer and method for treatment of bacterial infection

Also Published As

Publication number Publication date
EP3416656A4 (en) 2019-11-13
EP3416656B1 (en) 2021-04-21
EP3416656A1 (en) 2018-12-26
AU2017220391B2 (en) 2023-01-19
US20180338994A1 (en) 2018-11-29
JP6812436B2 (ja) 2021-01-13
AU2023201883A1 (en) 2023-05-04
AU2017220391A1 (en) 2018-05-17
ES2867453T3 (es) 2021-10-20
WO2017139849A1 (en) 2017-08-24
US20210275573A1 (en) 2021-09-09
CN108472311B (zh) 2021-06-22
CN108472311A (zh) 2018-08-31
US11045491B2 (en) 2021-06-29
JP2019510731A (ja) 2019-04-18

Similar Documents

Publication Publication Date Title
IL257384A (en) Preparations containing rnai and their use for the treatment of infection with the hepatitis b virus
HK1251554A1 (zh) 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮
HK1248711A1 (zh) 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮
HRP20190352T1 (hr) Novi 6-kondenzirani heteroarildihidropirimidini za liječenje i profilaksu infekcije virusom hepatitisa b
HK1223931A1 (zh) 用於治療和預防乙型肝炎病毒感染的新型二氫喹嗪酮類化合物
HK1231402A1 (zh) 治療 型肝炎和 型肝炎病毒感染的方法
IL263368A (en) Prevention and treatment of viral infections
EP3512524A4 (en) METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
HK1252343A1 (zh) 用於治療病毒感染的組合物和方法
HK1251010A1 (zh) 用於治療乙型肝炎病毒(hbv)感染的試劑及用途
ZA201902385B (en) Compounds and methods for diagnosis and treatment of viral infections
SI3137078T1 (sl) Zdravljenje okužbe s hepatitis delta virusom
HUE054191T2 (hu) A hepatitis delta vírusfertõzés kezelése
PL3183003T3 (pl) SPOSOBY ZAPOBIEGANIA l/LUB LECZENIA ZAKAŻENIA
EP3226973A4 (en) Treatment of hepatitis delta virus infection
EP3538108A4 (en) METHOD FOR TREATING OR INHIBITIONING AN EBOLA VIRUS INFECTION
HK1254547A1 (zh) 抗病毒劑和治療病毒感染的方法
EP3574089A4 (en) ANTIVIRAL AGENT AND METHOD OF TREATMENT OF A VIRAL INFECTION
GB201615035D0 (en) Treatment and prevention of viral infection
GB201615550D0 (en) Detection and treatment of microsporidian infection
EP3426659A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF ZIKA VIRUS INFECTION
IL286484B (en) Reagents for treatment of hepatitis b virus (hbv) infection and use thereof
GB201608352D0 (en) Apparatus for and method of treating viral infections
GB201608355D0 (en) Apparatus for and method of treating viral infections
GB201608348D0 (en) Apparatus for and method of treating viral infections